Atlas Trials

Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients

Clinical trial NCT00857324 · TERMINATED

Trial details

NCT number
NCT00857324
Sponsor
Tiziana Marangon
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2009-03-01
Primary completion
2012-03-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.